German Court Opens Door on Embryonic Stem Cell Patents
By Cormac Sheridan
Tuesday, December 4, 2012
More than a year on from a controversial opinion from the Court of Justice of the European Union (CJEU) on the patentability of innovations derived from embryonic stem cell (ESC) research, Germany's Federal Court of Justice (Bundesgerichtshof) has provided a final decision in the case, which leaves some scope for patent grants in that field.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.